Tradition Wealth Management’s Amylyx Pharmaceuticals AMLX Stock Holding History

Tradition Wealth Management’s Portfolio AMLX Stock Details AMLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-500	Closed	-$9K	–	1270
2023 Q3	$9K	Hold	500	–	–	﹤0.01%	1025
2023 Q2	$11K	Hold	500	–	–	﹤0.01%	1014
2023 Q1	$15K	Hold	500	–	–	﹤0.01%	891
2022 Q4	$18K	Hold	500	–	–	﹤0.01%	769
2022 Q3	$14K	Hold	500	–	–	﹤0.01%	836
2022 Q2	$10K	Buy	+500	New	+$5.94K	﹤0.01%	816

Other funds holding AMLX

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tradition Wealth Management's AMLX Position: Q4 2023 in Review

Tradition Wealth Management sold out of Amylyx Pharmaceuticals (AMLX) in Q4 2023, closing a stake of 500 shares — an estimated $9K sold.

Tradition Wealth Management first reported a position in AMLX in Q2 2022 and held it in 6 quarters. The position peaked at $18K in Q4 2022. 178 funds tracked by Wall St. Rank hold AMLX as of Q4 2023.

Tradition Wealth Management reported no remaining Amylyx Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
Tradition Wealth Management sold 500 Amylyx Pharmaceuticals shares in Q4 2023, an estimated $9K.
Tradition Wealth Management first reported a position in Amylyx Pharmaceuticals in Q2 2022 and held it in 6 quarters.
Tradition Wealth Management's Amylyx Pharmaceuticals position peaked at $18K in Q4 2022.
178 funds tracked by Wall St. Rank held Amylyx Pharmaceuticals as of Q4 2023.

Based on Tradition Wealth Management's 13F filing for Q4 2023, filed 12 Feb 2024.